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(57) ABSTRACT 
Real time cardiac electrical data are received from a patient, 
manipulated to determine various useful aspects of the ECG 
signal, and displayed in real time in a useful form on a 
computer screen or monitor. The monitor displays the high 
frequency data from the QRS complex in units of 
microvolts, juxtaposed with a display of conventional ECG 
data in units of millivolts or microvolts. The high frequency 
data are analyzed for their root mean square (RMS) voltage 
values and the discrete RMS values and related parameters 
are displayed in real time. The high frequency data from the 
QRS complex are analyzed with imbedded algorithms to 
determine the presence or absence of reduced amplitude 
zones, referred to herein as "RAZs". RAZs are displayed as 
"go, no-go" signals on the computer monitor. The RMS and 
related values of the high frequency components are dis- 
played as time varying signals, and the presence or absence 
of RAZs may be similarly displayed over time. 
34 Claims, 16 Drawing Sheets 
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REAL-TIME, HIGH FREQUENCY QRS 
ELECTROCARDIOGRAPH 
adequately satisfy the Nyquist rate of sampling at least twice 
the highest frequency of interest and in order to retain the 
information in the signal without loss. In the past, the 
sampled data have been stored, and then later processed to 
provide potentially useful information to the researcher. 
On the other hand, Simpson, in U.S. Pat. No. 4,422,459, 
teaches a system which analyzes only the late portion of the 
QRS interval and early portion of the ST segment, and in an 
off-line fashion (i.e. from previously stored data) to indicate 
diac arrhythmia. The late Portion of a Post myocardial 
infarct Patient’s QRS waveform contains a high frequency 
(40-250 Hz) signal tail which is indicative of a tendency 
toward ventricular tachycardia. The system in Simpson 
15 digitally processes and filters a patient’s QRS signals in a 
reverse time manner to isolate the high frequency tail and 
The invention described herein was made by employees 
of the United States Government and may be manufactured 5 
and used by or for the government for government purposes 
without payment of any royalties thereon or therefore. 
FIELD OF THE INVENTION 
The present invention relates generally to the field of 10 cardiac abnormalities, in particular the propensity for car- 
electrocardiography, and more particularly to a real-time 
processing system and method to analyze and display elec- 
trocardiographic signals. 
BACKGROUND OF THE INVENTION 
Diagnosis of abnormal cardiac conditions has relied in the 
past on visible alterations in the p, QRS, and T-waves, i,e, 
portions ofthe electrocardiograph periodic signal, The elec- 
avoid the ringing which hide the 
Thus, in Order to do so, Simpson presupposes that the 
trocardiograph includes a low frequency and 
an impressed or imbedded high frequency portion, and it has 2o Order. 
been found that although the higher frequency portion of the 
data are stored so that they can be processed in reverse time 
Albert et al., U.S. Pat. No. 5,117,833, Partially focuses on 
signal is not particularly visible, it contains information that 
provides greater sensitivity in determining certain 
analyzing signals within the mid-portion of the QRS interval 
for the indication of cardiac abnormality. The system of 
abnormalities, notably myocardial ischemia and infarction. 
insensitive diagnostic tool, F~~ a significant per- 
with an actual myocardial infarction (heart attack) will 
Albert et al. a known technique of building UP data 
ne conventional electrocardiogram (ECG) can be a very 25 points to derive an average of heartbeat characteristics in 
order to enhance signal to noise ratio. Data are collected and 
system does not teach a cardiac monitor which provides the 
centage of individuals presenting to a hospital emergency 
have a normal 12-lead conventional ECG. In addition, the 
and then stored for subsequent Thus, the 
from the data derived from a data 
conventional ECG accurately reflects only the predominant 30 patient, 
low-frequency electrical activity of the heart. It tells the Albert et al., U.S. pat. No. 5,046,504, similarly teaches 
clinician little or nothing about the less predominant high the acquisition of QRS data and subsequent analysis. ROU- 
frequency components of the heart’s electrical signal tine calculations are performed from the data previously 
embedded within the various lower-frequency waves of the 35 calculated and stored. Further, this system teaches producing 
conventional ECG. a set of digital spectrum values representative of an approxi- 
mate power density spectrum at each Of a large number Of 
higher frequency components within the central portion of generally spaced time Of the ECG 
in 
From off-line studies, it is known that a diminution ofthe 
the QRS complex of the ECG can be a highly sensitive waveform. 
indicator for the presence of myocardial ischemia or 40 Seegobin, in U.S. pat. Nos. 5,655,540 and 5,954,664, 
infarction, more sensitive, for example, than changes in the Provides a method for identifying coronary artery disease. 
ST segment of the conventional low-frequency electrocar- The method relies on a database of high and low frequency 
diagram, However, until now, there has been no device ECG data taken from known healthy and diseased subjects. 
capable of displaying, in real time, changes in these high Comparison of the data has led to a ‘‘Score’’ component, 
frequency QRS components in the monitored patient, While 45 indicating deviation of a patient’s data from the norm. This 
academic software programs have been designed that ana- reference is rather calculation intensive, and does not sug- 
lyze the central high frequency QRS components, all such gest monitoring the condition of a Patient, but rather is 
programs involve laborious off-line calculations and post- utilized as an Off-line diagnostic tool. 
processing, and therefore have little if any clinical utility, Hutson, U.S. Pat. No. 5,348,020, teaches a technique of 
being strictly research tools. Thus, there remains a need for 50 near real-time analysis and display. The technique includes 
a system and method that analyzes high frequency compo- inputting ECG data from multiple, sequential time intervals 
nents over the entire QRS interval in real time for usefulness and formatting those data into a two-dimensional matrix. 
in the clinical environment. Such a system should perform, The matrix is then decomposed to obtain corresponding 
in real time, all of the complex digital sampling, averaging, singular values and vectors for data compression. The com- 
and filtering that is required to generate high frequency QRS 55 pressed form of the matrix is analyzed and filtered to identify 
ECG signals. The system should also thereafter update these and enhance ECG signal components of interest. As with 
high frequency QRS ECG signals, as well as other derived other systems, this reference focuses on late potentials, a 
parameters, in real time on a beat-to-beat basis, supplement- fraction of the QRS interval, as the tool to identify cardiac 
ing the diagnostic information being obtained from the disease. 
Conventional 6.e. low frequency) ECG complexes at the 60 Finally, High-Frequency Electrocardiogram Analysis of 
same time. the Entire QRS in the Diagnosis and Assessment of Coro- 
The higher frequency signals in the central portion of the nary A r t e y  Disease by Abboud (Progress in Cardiovascular 
QRS ECG complex that have generated the most research Diseases, Vol. XXXV, No. 5 (MarchiApril), 1993: pp 
interest in terms of off-line detection of ischemia and inf- 311-328) teaches the concept of “reduced amplitude zone” 
arction are those signals in the range of 150 to 250 Hz. The 65 (RAZ) as a diagnostic tool. However, this reference also 
raw, analog ECG signal is typically sampled at 2500 uses post-processing, and provides no teaching of a real- 
samples per second (to digitize the signal) in order to time analysis system. 
US 7,113,820 B2 
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Thus, there remains a need for an electrocardiograph that 
analyzes, in real time, the high frequency components of the 
QRS complex in order to provide an effective monitor for 
patients with specific cardiac function abnormalities. The 
present invention is directed to such an electrocardiograph. 
SUMMARY OF THE INVENTION 
The present invention addresses these and other needs in 
the art by providing a real time display of various aspects of 
the QRS complex. The invention also provides a system for 
such a display, and a method of displaying such aspects. 
The present invention advances the state of the art by 
taking high frequency electrocardiographic data immedi- 
ately as they are sensed from a patient, manipulating the data 
in conjunction with the conventional low frequency signals, 
and displaying the high frequency data in real time in a 
useful form on a computer screen or monitor. In one aspect, 
the invention displays the high frequency data from the QRS 
complex in microvolts adjacent to a display of the conven- 
tional ECG data in millivolts. In another aspect of the 
invention, the high frequency data are analyzed for their root 
mean square (RMS) voltage values (as well as for related 
values such as the high frequency energy (HFQE) and high 
frequency integral of absolute value (HFAV), both described 
hereinafter), with the discrete, lead-by-lead values being 
displayed in real time as useful diagnostic indicators for 
ischemia. Also, the high frequency data from the QRS 
complex are analyzed with imbedded algorithms to deter- 
mine the presence or absence of reduced amplitude zones, 
referred to hereinafter as “RAZs”. The given RAZ, of which 
there are at least three possible variations (Le., the “Abboud” 
RAZ, the “NASA” RAZ, and the skewness-kurtosis or 
“S-K’ RAZ, all described below), is displayed as a real-time 
“go, no-go” signal on the screen. Finally, in still another 
aspect of the invention, not only the presence or absence any 
one of the three variations of RAZs, but also the RMS and 
related values (HFQE and HFAV) are displayed against time 
as time varying signals. 
In still another aspect of the invention, the electrocardio- 
graph of this invention detects and aligns R-waves and QRS 
complexes and analyzes these ECG signals after digitization 
at high sampling rates of at least 500 samples per second, but 
preferably at sampling rates of 1000 samples per second or 
greater. The system also signal averages consecutive QRS 
electrocardiographic complexes in a user-adjustable fashion 
to increase the signal-to-noise ratio. The resulting averaged 
signal is filtered, using non-recursive digital bandpass filters 
with varying high and low frequency cutoffs, and displayed 
in real time along with several other derived numerical 
measures described herein including the power spectrum of 
the filtered data. The resulting displays provide a clinician 
with real-time information with respect to changes in the 
high frequency ECG complex that may be indicative of 
myocardial ischemia, myocardial infarction, or of changes in 
myocardial conduction that are unrelated to myocardial 
ischemia or infarction. 
The invention includes a number of features that are 
neither shown nor suggested in the art, including a real-time 
display of cardiac electrical data that have been manipulated 
in such a way as to provide a clear indication of ischemia and 
infarction. The invention further includes a number of user 
selectable parameters to enhance the information provided 
to the clinician. Finally, the invention provides a number of 
displays, juxtaposed in real time, to provide a side-by-side 
comparison of various aspects of the QRS complex in real 
time. 
4 
These and other features of the invention will be apparent 
to those of skill in the art from a review of the following 
detailed description along with the accompanying drawings. 
BRIEF DESCRIPTION OF THE DRAWINGS 5 
FIG. 1 is a schematic diagram of the overall system of this 
FIG. 2 is a schematic diagram of a detail of FIG. 1. 
FIG. 3 is a schematic diagram of the logic carried out by 
the invention. 
FIG. 4 is a real-time screen display, showing character- 
istic data obtained from a healthy subject, including a 
side-by-side display of a standard ECG and a filtered (high 
FIG. 5 is a real-time screen display, showing character- 
istic data obtained from a patient having known cardiac 
disease, including a side-by-side display of a standard ECG 
and a filtered ECG. 
FIGS. 6 and 7 are real-time screen displays, showing the 
configuration of a QRS detector for a normal, healthy 
subject and for a patient having known cardiac disease, 
respectively. 
FIGS. 8 and 9 are real-time screen displays of cross 
correlation between a running, continuously updated 
waveform, or template, and a sensed waveform to determine 
departure from the template from one heartbeat to the next. 
FIGS. 10 and 11 are real-time screen displays of short 
30 term trends of various data for a healthy subject and for a 
patient having known cardiac disease, respectively. 
FIGS. 12 and 13 are real-time screen displays of long term 
trends of various data for a healthy subject and for a patient 
having known cardiac disease, respectively 
FIGS. 14 and 15 are real-time screen displays of high 
frequency QRS skewness versus kurtosis for a healthy 
subject and for a patient having known cardiac disease, 
respectively. 
FIGS. 16 and 17 are real-time screen displays of the 
spectrum of power for normal and diseased patients, respec- 
tively. 
invention. 
10 
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DETAILED DESCRIPTION OF A PREFERRED 
EMBODIMENT 
45 
FIG. 1 shows a simplified, functional, block diagram of a 
real-time high frequency QRS electrocardiograph 10 con- 
structed in accordance with the present invention. The 
invention monitors the cardiac function of a patient with a 
50 plurality of patient electrodes 12. The electrodes provide 
measurements of cardiac electrical function at various con- 
tact points on the skin of a patient in the conventional 
manner. For example, in the conventional 12-lead 
configuration, 10 electrodes placed upon the skin of the 
55 patient in the conventional configuration result in eight 
channels of incoming data. These eight channels are in turn 
translated into 12 leads of data on the patient monitor 
inasmuch as data for one of the bipolar limb leads and for all 
of the augmented unipolar limb leads can be derived if data 
60 for any two of the bipolar limb leads are already known. The 
analog measurements are coupled to a console 14 by way of 
a communications channel such as for example a cable 13. 
The console components are shown in greater detail in FIG. 
2. 
The console 14 conditions and digitizes the analog signal 
and provides the digitized signal to a computer 16 by way of 
a communications channel 15, which may preferably be a 
6 5  
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conventional cable or a wireless communication channel by 
radio frequency wave. The structure and function of the 
computer is shown and described below in respect of FIG. 
3. The computer 16 is programmed to display the ECG 
signal in real time, although the ECG signal may also be 
stored on a digital recording medium 18 over a communi- 
cations channel 17 for later display over a communications 
channel 17’. 
The computer 16 is coupled to a user interface 20 which 
preferably includes communications devices 22 such as a 
mouse, keyboard, andor touch screen. The user interface 
further includes a monitor 24 for user controllable graphic 
display of the ECG and various aspects of the signal, a 
feature of the present invention. The computer 16 is coupled 
to the interface 20 by way of bidirectional communications 
channels 19 and 19’, for example. The aspects of the 
graphical display are shown in greater detail and described 
below in respect of FIGS. 4 through 17. 
FIG. 2 depicts the structure of the console 14 in greater 
detail. As previously described, the patient is wired with a 
set of electrodes 12, such as for example a conventional set 
of ten electrodes for a 12-lead electrocardiograph to monitor 
cardiac function from different aspects of the patient’s body. 
The electrodes 12 provide a set of analog electrical signals 
to the console 14, where they are received by a pre-amplifier 
30 to boost the amplitude of the weak ECG signals. The 
amplified signals are then fed to an anti-aliasing filter 32. 
The filtered signals are then fed to an analog to digital 
converter 34, where the signals are digitized at least the 
Nyquist rate, preferably 1,000 Hz or greater, to retain all of 
the information contained in the analog signals. The 
sampleddigitized signals are then sent to the computer 16 
by an appropriate medium 15. 
The operation of the computer 16 is depicted in FIG. 3. 
The console 14 feeds the digitized ECG signals to the 
computer via a communications channel 15, as previously 
described. The computer 16 also interfaces with the user 
interface 20. The computer 16 receives the ECG signals into 
a device driver 40, which is simply the interface device and 
program for the console and computer. The device driver 40 
provides the ECG signals in parallel to an R-wave detection 
block 42 to synchronize the system for the start of each 
heartbeat by locating the fiducial point. The following 
requirements must be met for temporal averaging to work 
effectively. First, the signal of interest must be repetitive and 
relatively invariable. Time varying signals, such as ectopic 
or premature complexes, are eliminated before averaging by 
comparing incoming signals against a previously established 
template through the use of a real-time cross-correlating 
technique. Second, the signal of interest must be timelocked 
to a fiducial point, such as near the peak of the QRS 
complex, that is easily detectable and serves as a timing 
reference for the averaging algorithm. If the signal of 
interest does not have a fixed, temporal relationship with the 
timing reference point, the resultant averaged signal will be 
filtered and distorted due to reference jitter, with subsequent 
loss of the high frequency components. Third, the signal of 
interest and the noise must be independent and remain 
independent during averaging. 
Once the fiducial point has been located for each incom- 
ing beat, the digitized signals are fed to block 44 where 
initial templates of the QRS complexes are generated. The 
present invention includes running signal averages of the 
QRS complexes that constitute templates, with the number 
of individual beats in the running templates being selectable 
by the user on the user interface 20. The user can also 
determine the percent of cross-correlation between each new 
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incoming beat and the templates which will be detected as 
a departure from the norm, and which channel(s) that will be 
used for the cross-correlation functions. 
With the user-selected inputs as just described, the system 
in block 48 runs a real-time cross-correlation function on 
each subsequent incoming beat. In block 50, those beats 
which are below the threshold set by the user (or set by the 
system default) are rejected, with block 52 accepting only 
well-correlated beats to create the running templates. This 
feature helps to eliminate noisy, unreliable waveforms when 
creating the running templates. From this block, the user 
interface displays a continuously updated running total of 
the number of beats accepted and rejected in block 51, a 
feature of the invention. 
Block 54 then aligns the beats by detecting and adjusting 
for any signal jitter, which may be created by any number of 
well-known factors, including minor inconsistencies in the 
detection of the fiducial point, movement by the patient or 
even respiration by the patient. The aligned, jitter-corrected 
waveform is then fed to block 56, a band-pass filter, pref- 
erably 150-250 Hz, to select only the frequencies of interest 
in the waveform. Finally, the band-pass signals are fed to 
block 58, where, in the present embodiment, the eight 
channel to 12-lead conversion is performed. 
From this point in the diagram of FIG. 3, blocks 62, 64, 
68, 70, and 72 describe data which are displayed on the user 
interface 20, as shown in FIGS. 4 through 17. Block 62 
shows the instantaneous, real-time high frequency filtered 
QRS signal for each lead, updating with each new beat as 
that beat is incorporated into the average beat. Beats that are 
poorly cross-correlated are rejected and thus the template 
averages and the display will not be altered by such beats. 
The display is shown by element number 114 in FIG. 4. 
Block 64 determines the unfiltered QRS interval onset and 
offset automatically and in real time. This block receives an 
input from block 54 which detected and adjusted for any 
jitter in the well cross-correlated beats. The cross-correlation 
and jitter-correction from block 54 are therefore also dis- 
played on the user interface, as shown in FIGS. 8 and 9. 
Block 68 describes the display of the instantaneous high 
frequency QRS RMS, HFQE and HFAV voltages and power 
spectrum generated for each lead using the unfiltered QRS 
interval onset and offset, and shown in FIG. 4 as element 
numbers 116 and 128. 
Block 70 describes the running plots of the RAZs (“go/ 
no-go”) as well as the voltages for the RMS, HFQE and 
HFAV of the high frequency QRS ECG signal versus time 
for each lead as depicted in FIGS. 10 through 13. FIGS. 10 
(healthy subject) and 11 (subject withknown coronary artery 
disease) depict short-term data trends whereas FIGS. 12 
(healthy subject) and 13 (subject with known coronary 
artery disease) depict longer-term data trends. The horizon- 
tal (time) axis scale is user-adjustable on both the long and 
short-term trend plots, and can be shown either in beats (as 
depicted here) or in seconds. Clinicians can utilize these 
trends to assess how a monitored patient’s cardiac function 
has changed over time, up to and including the present time. 
Specifically, clinicians can identify whether and when RAZs 
have developed or disappeared during the period of 
monitoring, as well the degree to which the RMS and related 
voltages of the high frequency QRS complex have changed 
over the same period of monitoring. Realization of such 
changes is particularly valuable to clinicians during situa- 
tions when the presence or absence of incipient myocardial 
ischemia or infarction needs to be immediately identified, 
when the success or failure of invasive or noninvasive 
US 7,113,820 B2 
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treatments administered for ischemia and infarction needs to displaying the presence or absence of RAZs on the same 
be immediately recognized, andor when cardiovascular display to alert the clinician to potentially abnormal cardiac 
responses during pharmacological or exercise stress tests or function. 
during a patient’s ambulatory activities needs to be assessed. The display of FIGS. 4 and 5 includes a conventional, low 
Finally, block 72 describes another feature of the 5 frequency ECG signal, designated by the element number 
invention, online instantaneous RAZ detection for each lead. 112. The display signal 112 includes the signals from leads 
The presence of a “RAZ”, or “reduced amplitude zone” I, 11, 111, aVR, aVL, aVF, and V1-V6 in the conventional 
within the envelope of the averaged high-frequency QRS manner. Further, the display signal 112 slides from left to 
signal, may be an indication of abnormal cardiac function. A right, updated with each beat, also in the conventional 
RAZ, as originally defined by Abboud (but only in the manner, as a reference for the clinician. Positioned imme- 
context of off-line analyses), classically occurs when at least diately adjacent to or below the conventional ECG display 
two local maxima of the upper envelope or two local minima 112 is a display 114 of a running, instantaneous filtered (i.e. 
of the lower envelope are present within the high frequency high frequency) QRS ECG signal, one for each of the twelve 
as an envelope sample point (peak or trough) within the QRS 15 112. The display signal 114 includes the signals from leads 
interval wherein the absolute value of its voltage exceeds I, 11, 111, aVR, aVL, aVF, and V1-V6 to correspond to like 
that of the three envelope sample peaks immediately pre- signals in the display 112. Above each high frequency QRS 
ceding and following it. The RAZ is thus the region lying signal is the instantaneous RMS value 116 in that particular 
between the two neighboring maxima or minima. The lead, and an instantaneous RAZ indicator 117, defaulted to 
present invention performs a real-time calculation, looking 2o the RAZ type of the user’s choice (in this case the RAZ,). 
for local maxima and minima of the QRS envelope not only At the bottom of the screen display of FIGS. 4 and 5 is a 
according to previously published off-line criteria ofAbboud tool bar 120. The tool bar 120 provides user control and 
(Le., “RAZ,”, or the Abboud RAZ) but also separately and display of various data useful to the clinician. The tool bar 
especially according to new criteria that improve the speci- includes a user selectable indicator 122 in which the user can 
ficity and accuracy of RAZ detection, particularly for the 25 select which of a plurality of QRS complexes to capture. 
online setting. Displays 124, 126, and 128 show the timing of the QRS 
One especially important modification contributing to onset, QRS offset, and the duration of the QRS complex, 
such improvement is the requirement that the second, respectively. A display 130 shows the total number of 
signal that defines the presence of the RAZ be at least two 30 run, while a display 132 shows the number of beats rejected 
times, and optionally up to three to four times, larger in and a display 134 shows the number of beats whose pro- 
amplitude than the RMS “noise” of the high frequency cessing is pending, if any. Toggle buttons 136 and 138 
signal that is present outside of the QRS interval (i.e., in any permit the user to turn on and turn off the cross correlation 
given chosen segment within the PR, ST or TP intervals). function and the beat rejection function, respectively. Dis- 
Another modification criterion implemented optionally by 35 play buttons 140,142,144, and 146 permit the user to select 
the user into the online RAZ detector is that the absolute other displays for the screen, as shown. A toggle button 148 
value of the amplitude of the smaller of the two local permits the user to turn on and turn off an autoscale function, 
maxima (or minima) constituting the RAz must be at least and a print button 148 permits the user to print a particular 
a certain percentage of that of the larger of the two local screen capture at his discretion. 
maxima (or minima). These modifications as optionally 40 Of particular note, in comparing FIGS. 4 and 5, is the 
implemented by the user within the present invention, small number of reduced amplitude zones and lit RAZ 
together with the requirement that at least two local maxima indicators 117 for the healthy patient shown in FIG. 4, versus 
of the upper envelope “and” (rather than “or”) two local the much larger number of reduced amplitude zones and lit 
minima of the lower envelope be present to constitute a RAZ indicators for the subject with known coronary artery 
RAZ, are collectively referred to as the criteria that define 45 disease, shown in FIG. 5. 
the “NASA RAZ”, or “RAZ,”. FIGS. 6 and 7 show configuration screen 160 for the 
Yet another novel set of user-selectable criteria used in the online QRS interval detector of the invention, selectable by 
present invention to assess the presence or absence of a button 146 of FIGS. 4 and 5. The configuration screen of 
“statistical” type of RAZ concerns the use of real-time FIGS. 6 and 7 permits the user to select a period within the 
calculation of the both the skewness and the kurtosis of the 50 P-R interval of the ECG, with specific pre-Q offset and 
incoming high frequency QRS signal. When present, the interval width selectors 162 and 164, respectively, that will 
skewness-kurtosis type of RAZ is referred to as the RAZ,,. aid in the determination of the onset of the QRS complex. 
The presence of a RAZ,, RAZ,, andor RAZ,, by “goino- The values for these parameters shown in FIGS. 6 and 7 
go” indicators on the display, as shown by element 117 in have been selected based on initial experience to provide 
FIG. 4, may also be displayed as a running parameter with 55 satisfactory performance of the invention for the broadest 
time, in a manner similar to FIGS. 10-13. array of subjects, since cardiac function typically varies 
Referring now more particularly to FIGS. 4 and 5, a from patient to patient. Similarly, selectors 166 and 168 
feature of the present invention is the simultaneous display permit the user to select the offset and width, respectively, of 
in real-time of various aspects of cardiac function with a portion of the ST segment that will aid in the determination 
respect to both the conventional and high frequency QRS 60 of the offset of the QRS complex. The configuration screen 
ECG. Further, the present invention provides simultaneous, 160 also displays various parameters measured from the 
side-by-side or vertical displays of that data to provide the current heartbeat, as shown. An indicator 170 shows the user 
clinician with a tool to compare these aspects of the ECG which of the leads is selected, in the case of FIGS. 6 and 7 
with one another for a more complete picture of cardiac that lead is lead 11. A RAZ indicator 117 is also provided for 
function than has been previously available. The present 65 the convenience of the user. 
invention also displays the conventional and high frequency FIGS. 6 and 7 also include superimposed displays of a 
12-lead configurations on one user interface display, while low frequency signal averaged ECG 172 and an averaged 
QRS signal. A local maximum or minimum is in turn defined leads, corresponding to the individual leads of the display 
smaller local maximum within the high frequency QRS heartbeats which have been detected during any particular 
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high frequency filtered signal 174. The ordinate on the left 
of FIGS. 6 and 7 shows the averaged low frequency signal 
172 in millivolts, and the ordinate on the right shows the 
averaged high frequency signal 174 in microvolts. 
FIG. 6 shows a single local maximum 176 and a single 5 
local minimum 178. However, FIG. 7, depicting the wave- 
forms for a patient with known coronary artery disease, 
shows two local maxima 180 and 182, and two local minima 
lent to the “area under the curve” of the power spectrum, 
defined as 
ufqsll 
,=ufqon 
R M S =  ~ F UFQRSD 
184 and 186. Since the maxima and/or minima occur within at a given Point, 
the QRS complex, and are separated by at least three 10 @on andufqoffarethe onset and offset, respectively, ofthe 
where x~ is the 
QRS interval, and UFQRSD is the unfiltered QRS interval 
duration as defined by ufqon and ufqoff. In this context, the 
term “onset” means the start of the QRS interval, and the 
term “offset” means the end of the QRS interval. This is the 
used in preferred embodiment of 
the present invention, 
signal have also been proposed (and used strictly in an 
off-line fashion) by Xue et al. (see Xue, Q., B. R. Reddy, and 
envelope sample points with lesser absolute amplitudes 
between them, they define a reduced amplitude zone as also 
shown on the lit RAZ indicator 117. 
invention. The screen 190 is selected by a user with button 
template, averaged over a user selectable number of beats. A 
Of the current 
FIGS. 8 and 9 depict cross correlation screens 190 of the 15 primary numerical 
144 4). The a 192 Of a Other numerical measures of the high frequency QRS 
194 shows the low frequency 
beat, and a 196 shows the cross between T, Aversano, Analysis of high-frequency signal-averaged 
the waveforms Of 192 and may 2o ECG measurements, J Electyocaydiol 28: 239-45, 1995). 
gral of absolute values (HFAV) and the high frequency QRS 
194. A 
select the threshold for the cross correlation, below which 
rejected, an indicator light 198 illuminates. 
display 194 is noisy and has a different shape than the 
These numerical include the high frequency inte- 
energy (HFQE). Xue et al. have defined HFAV and HFQE as 
the beat is rejected, by a 197 and, if a beat is 
Note that in FIG. 9 the current heartbeat shown on the 25 f o ~ ~ o w ~ :  
template. The current beat is also shifted in time from the 
between them is poor, as reflected in the display 196, which 
u q o f t l 0  ms 
I=uqon-lomS 
template of display 192. Consequently, the cross correlation HFAV = I x , - A V N d  
and, 
only has a peak of 0.951 (Le. below the user selectable 3o 
threshold set at 0.970 in this case) and the beat is rejected, 
as shown by the indicator light 198. Thus, the current beat 
ECG. 
FIGS. 10 through 13 depict trend lines for the RMS, 35 
HFQE, and HFAV, as well as show the current value for wherein A W L  equals the average noise level of the filtered 
these parameters. These displays further include lines Signal in the ST segment in a 40 ms window located 60 ms 
depicting the presence versus the absence of three types of from the QRS offset. It should be noted that in their own 
RAZ as described herein. These displays illustrate another definitions for HFAV and HFQE (as dmwn above), Xue et 
feature of the present invention, that of showing a trend of 40 al. ‘‘pad’’ both the QRS onset and offset by extra 10 ms each 
parameters over time. Specifically, the trend lines shown on in an effort to reduce noise and noise variability, Presumably 
illustrate the presence (versus the absence) of all three types related to the determination of the QRS interval. 
of RAZs over a user-selectable period of time (always up to In the Presently Preferred mhodiment of the Present 
and including the present time) as well as the voltage trends 45 invention, the definitions for HFAV and HFQE are mdified 
for RMS, HFQE and HFAV over this Same user-selectable in two ways. First, because the present invention provides a 
period of time for all the leads attached to the patient. FIGS. means of viewing the high and low frequency ECG Signal in 
10 and 11 provide examples of trend lines on a short-term real time, thereby providing reliability for the determination 
time scale for a healthy subject and for a patient with known ofthe QRS interval, the necessity (or lack thereof) of using 
coronary artery disease, respectively, whereas FIGS, 12 and 5o the 10 millisecond padding periods is left to the discretion of 
13 provide corresponding examples of trend lines on a the user. Second, the present invention preferably uses the 
long-term time scale for these same individuals. The short PR interval Or TP segment rather than the ST segment to 
and long-term trend line plots can be accessed simulta- determine the AVNL of the baseline, since a segment of the 
neously by the user, and, to reiterate, the time intervals cardiac cycle wherein neither depolarization nor repolariza- 
(horizontal axes depicted here in units of beats) on both plots 55 tion is Present is Preferred. In the device of the Present 
are completely selectable by the user, The particular param- invention disclosed herein, AVNL is determined as the RMS 
eters depicted on these plots are intended to be illustrative noise of the filtered signal that is within a 25 ms interval in 
u q o f t  10 ms 
I=uqon-lomS 
HFQE = ( X ,  - A W L ) *  is not incorporated into the running template of the averaged 
a Screen 200, which are contin~ously updated in real time, to compensate for potential inaccuracies and inconsistencies 
only, and other parameters may be similarly illustrated. The 
ordinate for each plot is in microvolts with respect to the 
RMS, HFQE and HFAV (the RAZs are unitless, “go versus 60 
the PR segment. 
In the Preferred embodiment, HFAV is measured as: 
no-go” entities), whereas the abscissa can be in either beats w3f 
or seconds, for characterization of the trend. H F A V =  IX, - A V N d  
1=uqon 
Numerical measures of the high frequency QRS ECG 
may be calculated in several ways. These measures are 
important because they often decrease when ischemia is 65 wherein AVNL (average noise level) equals the “noise” of 
present. Perhaps the most popular measure is the root mean the high frequency (i.e., filtered) signal within that portion of 
square (RMS) voltage of the QRS signal, which is equiva- the PR interval just noted. 
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Further, high frequency QRS energy (HFQE) is calculated 
as: 
uvff 
HFQE = (X, - 
1=uqon 
wherein A W L  is determined in the same way as for HFAV. 
A useful characterization of a set of data includes skew- 
ness and kurtosis. Skewness is a measure of symmetry, or 
more accurately, the lack of symmetry. A distribution, or 
data set, is symmetric if it looks the same to the left and right 
of the center point. Kurtosis is a measure of whether the data 
are peaked or flat relative to a normal distribution. That is, 
data sets with a high kurtosis tend to have a distinct peak 
near the mean, decline rather rapidly, and have heavy tails. 
Data sets with low kurtosis tend to have a flat top near the 
mean rather than a sharp peak. Auniform distribution would 
be the extreme case. By displaying skewness values alone, 
kurtosis values alone, or skewness versus kurtosis graphi- 
cally with one value on the ordinate and the other on the 
abscissa, the clinician may obtain information from the high 
frequency QRS signals potentially indicative of cardiac 
disease. Referring to FIGS. 14 and 15, a display 250 is 
provided to show real-time, continuously updated plots of 
skewness versus kurtosis against a background line of a 
normal population distribution function. If a patient’s S-K 
data in any given lead fall on or above that lead’s distribu- 
tion function, the data for that lead are considered “normal”, 
as shown in most of the leads of FIG. 14, whereas data from 
any given lead falling below that lead’s distribution 
function, as shown in most of the leads of FIG. 15, provides 
a visual indication of potential cardiac disease, i.e., a posi- 
tive “RAZ,,”. 
Referring now to FIGS. 16 and 17, a display 270 is 
provided to show the power spectrum of the high frequency 
QRS signal for each lead. A change in the shape of the 
spectral plot such that two distinct peaks occur rather than 
one may be further indication of cardiac malfunction. 
The principles, preferred embodiment, and mode of 
operation of the present invention have been described in the 
foregoing specification. This invention is not to be construed 
as limited to the particular forms disclosed, since these are 
regarded as illustrative rather than restrictive. Moreover, 
variations and changes may be made by those skilled in the 
art without departing from the spirit of the invention. 
We claim: 
1. A method of monitoring cardiac function, comprising 
the steps of 
a. sensing an electrocardiograph signal, the signal com- 
prising a succession of waves; 
b. independently identifying the QRS complex with each 
successive wave continuously, in real time, and in a 
beat-by-beat manner; 
c. independently analyzing data from the succession QRS 
complexes relating to the cardiac function 
continuously, in real-time, and in a beat-by-beat 
manner, wherein the step of analyzing is comprised of 
band-pass filtering the data in a high frequency range 
between about 150 Hz and about 250 Hz; and 
d. displaying predetermined characteristics of all data 
contiuously, in real-time, and in beat-by-beat manner. 
2. The method of claim 1, further comprising the steps of 
developing measures related to the data from the succession 
QRS complexes and wherein the step of displaying is 
comprised of displaying the measures on a monitor. 
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3. The method of claim 1, wherein the step of analyzing 
generating an initial template of the signal using the first 
QRS complex from the first wave of the signal; 
cross-correlating each subsequent independently identi- 
fied QRS complex continuously and in a beat-by-beat 
manner aginst predetermined criteria wherein accepted 
QRS complexes are incorporated into the initial tem- 
plate to create a running signal average template in 
real-time; 
aligning each independently identified QRS complex with 
the running signal average template continuously, in 
real-time, and in a beat-by-beat manner; and 
calculating predetermined, selectable high frequency 
characteristics from the running signal average tem- 
plate in a continuous, beat-by-beatm, real-time manner. 
4. The method of claim 3, wherein the step of calculating 
wherein the reduced amplitude zone occurs when at least 
two local maxima or at least two local minima are 
present in the filtered data; and 
wherein each local maximum or each local minimum is a 
peak or a trough, respectively and wherein the absolute 
value of each peak or trough’s voltage exceeds that of 
a predetermined number of sample points within the 
filtered data immediately preceding and following each 
peak or trough. 
5. The method of claim 4, wherein the absolute value of 
the amplitude of the smallest of the at least two local 
maxima or the smallest of the at least two minima is at least 
30 a predetermined percentage relative to the largest of the at 
least two maxima or the largest fo the at least two minima, 
respectively. 
6. The method of claim 4, wherein the absolute value of 
the amplitude of the smallest of the at least two local 
35 maxima or the smallest of the at least two local minima is at 
least a predetermined multiple of the high frequency noise 
level of a predetermined iso-electric portion. 
7. The method of claim 3, wherein the step of calculating 
is comprised of calculating a skewness, kurtosis, or both of 
8. The method of claim 1, wherein the step of displaying 
is comprised of displaying the sensed signal from step 1 .a. 
adjacent the data from step 1. d. on a monitor. 
9. The method of claim 1, wherein the step of analyzing 
45 is further comprised of computing the presence or absence 
of reduced amplitude zones from the high frequency filtered 
data associated with the QRS complex. 
10. The method of claim 9, wherein the step of displaying 
is comprised of displaying the presence or absence of the 
11. An electrocardiograph system for monitoring cardiac 
a. means for sensing an electrocardiograph signal, the 
signal comprising a succession of waves; 
b. means for independently identifying the QRS complex 
with each successive wave, continuously, in real-time, 
and in a beat-by-beat manner; 
c. means for independently analyzing data from the suc- 
cessive QRS complexes relating to the cardiac function 
60 continuously, in real-time, and in a beat-by-beat 
manner, wherein the means for analyzing is comprised 
of a means for band-pass filtering the data in a high 
frequency range between about 150 Hz and about 250 
Hz; and 
d. means for displaying predetermined characteristics of 
all data continuously, in real-time, and in a beat-by-beat 
manner. 
is further comprised of 
5 
15 
is comprised of calculating a reduced amplitude zone, 
20 
25 
4o the filtered data. 
5o reduced amplitude zones on a monitor. 
function comprising: 
55 
65 
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12. The system of claim 11, wherein the means for 
displaying is comprised of displaying the sensed signal from 
step 9.a. on a monitor adjacent the data of step 9.d. 
13. The system of claim 11, wherein the means for 
analyzing is further comprised of a means for computing the 
presence or absence of reduced amplitude zones from the 
succession of high frequency QRS complexes. 
14. The system of claim 11, wherein the means for 
displaying all data comprises a monitor. 
15. An electrocardiograph system comprising: 
a. at least one electrode adapted to sense a conventional 
electrocardiogram signal comprising a succession of 
waves; 
b. an electrocardiogram console adapted to receive the 
conventional electrocardiogram signal from the at least 
one electrode and to independently identify the QRS 
complex with each successive wave continuously, in 
real-time, and in a beat-by-beat manner at at least the 
Nyquist rate; 
c. a computer coupled to the console to receive the 
conventional electrocardiogram signal, to band-pass 
filter data from the succession of QRS complexes in a 
high frequency range, and to indepently analyze the 
filtered data from the succession of QRS complexes 
continuously, in real-time, and in a beat-by-beat man- 
ner; and 
d. a monitor to display predetermined characteristics fo all 
data continuously, in real time, and in a beat-by-beat 
manner. 
16. The system of claim 15, wherein the monitor is further 
adapted to display the conventional electrocardiogram sig- 
nal and the predetermined characteristics of filtered data, 
analyzed data, or both adjacent one another in real time. 
17. The system of claim 16, wherein the computer’s 
ability to analyze the filtered data is comprised of calculating 
the presence or absence of reduced amplitude zones. 
18. The system of claim 17, wherein the monitor is further 
adapted to display the presence or absence of the reduced 
amplitude zones. 
19. The system of claim 15, wherein the computer’s 
ability to analyze the filtered data is comprised of calculating 
a real time cross correlation function from the succession of 
waves. 
20. The system of claim 15, wherein the computer’s 
ability to analyze the filtered data is comprised of generating 
a running a QRS template based on a user selectable number 
of waves. 
21. A display the electrocardiograph signal and data 
resulting from the method described in claim 1 comprising: 
a. a plot of at least one real-time low frequency compo- 
nent of the electrocardiogram signal; and 
b. a plot of at least one real-time high frequency compo- 
nent of the electrocardiogram signal derived from the 
filtered data, analyzed data, or both, wherein the plot of 
the at least one real-time low frequency component 
displayed adjacent the plot of the at least one real-time 
high frequency component. 
22. The display of claim 21, wherein the plot of the at least 
one real-time low frequency component electrocardiogram 
signal comprises a plurality of plots of real-time low fre- 
quency components of a plurality of electrocardiogram 
signals and the plot of the at least one real-time high 
frequency component of the electrocardiogram signal com- 
prises a plurality of plots of real-time high frequency com- 
ponents of a plurality electrocardiogram signals. 
23. The display of claim 21, wherein the low frequency 
and high frequency components of the electrocardiograph 
signal are a representation of cardiac function in real-time. 
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24. The display of claim 21, further comprising user 
selectable controls to alter the display. 
25. The display of claim 21, further comprising at least 
one indicator for the presence or absence of a reduced 
26. The display of claim 21, further comprising at least 
one plot of user selectable data measured over time. 
27. The display of claim 26, wherein the user selectable 
data are selected from the group consisting of root mean 
lo square voltage values, high frequency energy (HFQE), high 
frequency integral of absolute value (HFAV), RAZ,, RAZ,, 
and RAZ,,. 
28. A method of monitoring cardiac function, comprising 
15 the steps of: 
a. sensing an electrocardiograph signal, the signal com- 
prising a succession of waves; 
b. independently identifying the QRS complex with each 
successive wave continuously, in real-time, and in a 
c. indepently analyzing data from the succession of QRS 
complexes, wherein the step of analyzing is comprised 
of band-pass filtering the data in high frequency range 
between about 150 Hz and about 250 Hz, and evalu- 
ating the filtered data for the presence or absence of a 
reduced amplitude zone continuously, in real-time, and 
in a beat-by-beat manner; and 
d. displaying predetermined characteristics of all data 
continuously, in real-time, and in a beat-by-beat man- 
29. The method of claim 28, wherein the step of display- 
ing is further comprised of displaying the presence or 
absence of the reduced amplitude zones on the monitor. 
5 amplitude zone. 
20 beat-by-beat manner; 
25 
30 ner on a monitor. 
30. An electrocardiograph system comprising: 
a. means for sensing an electrocardiograph signal, the 
signal comprising a succession of waves; 
b. means for independently identifying the QRS complex 
with each successive wave continuously, in real-time, 
and in a beat-by-beat manner; 
c. means for independently analyzing data from the suc- 
cession of QRS complexes relating to the cardiac 
function, wherein the step of analyzing is comprised of 
band-pass filtering data in a high frequency range 
between about 150 Hz and about 250 Hz, and evalu- 
ating the filtered data for the presence or absence of 
reduced amplitude zones continuously, in real-time, 
and in a beat-by-beat manner; and 
d. means for displaying predetermined characteristics of 
all data continuously, in real-time, and in a beat-by-beat 
manner on a monitor. 
31. A method of monitoring cardiac activity, comprising 
a. sensing an electrocardiograph signal, the signal com- 
prising a succession of waves; 
b. independently identifying the QRS complex with each 
successive wave continuously, in real-time, and in a 
beat-by-beat manner; 
c. independently analyzing data on a computer processor 
of known type from the succession of QRS complexes 
relating to the cardiac activity continuously, in real- 
time, and in a beat-by-beat manner, the step of analyz- 
ing is comprised of band-pass filtering the data in a high 
frequency range between about 150 Hz and about 250 
Hz; and 
35 
40 
45 
50 
the steps of: 
55 
60 
6 5  
d. storing all data on a recording medium. 
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32. An electrocardiograph system comprising: 
a. means for sensing an electrocardiograph signal, the 
signal comprising a successin of waves; 
b. independently identifying the QRS complex with each 
successive wave continuously, in real-time, and in a 
beat-by-beat manner; 
c. means for independently analyzing data from the suc- 
cession of QRS complexes relating to the cardiac 
function continuously, in real-time, and in a beat-by- 
beat manner, the means for analyzing is comprised of 
means for band-pass filtering the data in a high fre- 
quency range between about 150 Hz and about 250 Hz; 
and 
d. means for recording all data. 15 
33. A method of monitoring cardiac function, comprising 
a. sensing an electrocardiograph signal, the signal com- 
prising a succession of waves; 
b. independently identifying the QRS complex with each 20 
successive wave continuously, in real-time, and in a 
beat-by-beat manner; 
c. independently analyzing data from the succession of 
QRS complexes, wherein the step of analyzing is 
the steps of: 
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comprised of band-pass filtering the data in a high 
frequency range between about 150 Hz and about 250 
Hz, and evaluating the filtered data for the presence or 
absence of a reduced amplitude zones continuously, in 
real-time, and in a beat-by-beat manner; and 
d. recording all data on a recording medium. 
34. An electrocardiograph system comprising: 
means for sensing an electrocardiograph signal, the 
signal comprising a succession of waves; 
means for independently identifying the QRS complex 
with each successive wave continuously, in real-time, 
and in a beat-by-beat manner; 
means for independently analyzing data from the suc- 
cession of QRS complexes relating to the cardiac 
function, wherein the step of analyzing is comprised of 
band-pass filtering the data in a high frequency range 
between about 150 Hz and about 250 Hz, and evalu- 
ating the filtered data for the presence or absence of 
reduced amplitude zones continuously, in real-time and 
in a beat-by-beat manner; and 
means for recording all data. 
* * * * *  
